Skip to main content

Table 1 Socio-economic characteristics, costs distributions, and treatment duration of children with leukemia

From: Disparities in economic burden for children with leukemia insured by resident basic medical insurance: evidence from real-world data 2015–2019 in Guangdong, China

Variables

Code

Freq. (%)

Variables

Code

Value

Demographic information

Total Costs & reimbursement (CNY/%)

Leukemia Type

ALL

596(77.9%)

Total Cost

Median

244,250.1

AML

111(14.5%)

IQR

156,330.8–357,847.4

Transplantation

58(7.6%)

Total OOP

Median

182,860.2

Hospitals

Nanfang H

469(61.3%)

IQR

112,324.1–266,849.7

Zhujiang H

296(38.7%)

Total Reimbursement

Median

47,575.45

Insurance Type

GZ-RBMI

75(9.8%)

IQR

0.00–115,375.0

GD-contracted

412(53.9%)

RR

Median

24.16

GD-uncontracted

60(7.8%)

IQR

0.00–39.74

Other-contracted

38(5.0%)

 

Other-uncontracted

46(6.0%)

Cost structures (CNY)

OOP

134(17.5%)

Operation/Procedure

Median

481.59

Year

2015

212(27.7%)

IQR

286.00–867.59

2016

147(19.2%)

Simple Treatment

Median

0.00

2017

170(22.2%)

IQR

0.00–0.00

2018

144(18.8%)

Blood Products

Median

12,095.00

2019

92(12.0%)

IQR

5760.00–24,125.00

Sex

Male

482(63.0%)

Drug

Median

91,486.07

Female

283(37.0%)

IQR

44,721.65–152,689.1

Age

0–5

419(54.8%)

 

6–10

190(24.8%)

Treatment Duration (Days)

11–15

156(20.4%)

Total Treatment Duration

Median

526.00

Region

GD-PRD

261(34.1%)

IQR

319.00–764.50

GD-Other

349(45.6%)

 

Outside GD

155(20.3%)

Total Inpatient Days

Median

164.00

Hukou

Urban

347(45.4%)

IQR

126.00–213.50

 

Rural

418(54.6%)

 
  1. Transplantation, the AML patients who received transplantation. GD-PRD, the Pear-River Delta cities in Guangdong Province. GD-Other, the other cities in Guangdong outside Pear-River Delta regions
  2. RR reimbursement rate, CNY Chinese Yuan, IQR interquartile range, OOP out-of-pocket payment, ALL acute lymphoblastic leukemia, AML acute myeloid leukemia